切换至 "中华医学电子期刊资源库"

中华临床实验室管理电子杂志 ›› 2014, Vol. 02 ›› Issue (01) : 38 -44. doi: 10.3877/cma.j.issn.2095-5820.2014.01.008

实验研究

FAK突变体的亚细胞定位及生物学特性
方旭前1, 刘湘帆2, 姚玲3, 顾志冬1, 陈长强1, 倪培华2, 郑新民3, 樊绮诗1,()   
  1. 1.201801 上海交通大学医学院附属瑞金医院北院检验科
    2.201801 上海交通大学医学院检验系
    3.201801 上海交通大学医学院基础医学院生化与分子生物学教研室
  • 收稿日期:2013-08-19 出版日期:2014-02-28
  • 通信作者: 樊绮诗
  • 基金资助:
    国家自然科学基金资助项目(81071745)

Subcellular location and biological characteristics of a FAK splicing mutant

Xuqian Fang1, Xiangfan Liu1, Ling Yao1, Zhidong Gu1, Changqiang Chen1, Peihua Ni1, Xinmin Zheng1, Qishi Fan1,()   

  1. 1.Department of Laboratory Medicine,Rui Jin North Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 201801, China
  • Received:2013-08-19 Published:2014-02-28
  • Corresponding author: Qishi Fan
引用本文:

方旭前, 刘湘帆, 姚玲, 顾志冬, 陈长强, 倪培华, 郑新民, 樊绮诗. FAK突变体的亚细胞定位及生物学特性[J/OL]. 中华临床实验室管理电子杂志, 2014, 02(01): 38-44.

Xuqian Fang, Xiangfan Liu, Ling Yao, Zhidong Gu, Changqiang Chen, Peihua Ni, Xinmin Zheng, Qishi Fan. Subcellular location and biological characteristics of a FAK splicing mutant[J/OL]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2014, 02(01): 38-44.

目的

探讨外显子33缺失型黏着斑激酶(focal adhesion kinase,FAK)突变体(FAK-Del33)的亚细胞定位及生物学特性。

方法

采用基础实验研究设计。将野生型FAK以及突变型FAK-Del33分别构建到pEGFP表达载体, 并转染乳腺癌细胞株, 以研究分析其细胞表达和定位情况。另构建过表达FAK或FAK-Del33的MDA-MB-468乳腺癌稳转细胞株,研究评价其细胞表达和体外克隆形成能力。

结果

构建FAK-GFP融合蛋白表达载体转染MDA-MB-468后的细胞定位显示,野生型FAK在胞浆中弥散分布,而FAK突变体蛋白在胞浆中呈点状不均匀分布,并聚集成簇。经限制性内切酶酶切分析与测序分析,成功构建出过表达FAK的慢病毒载体, 以293T细胞包装的重组慢病毒能够高效感染乳腺癌细胞;经抗生素puromycin筛选和荧光定量PCR鉴定,成功筛选到稳定表达FAK的细胞株。在软琼脂克隆形成实验中,FAK野生型的克隆形成数为(335±48)/1000个,FAK突变体为(735±91)/1000个,后者对MDA-MB-468乳腺癌稳转细胞株的增殖能力高于前者(t=9.437,P<0.01)。

结论

初步研究表明外显子 33 缺失可改变FAK的亚细胞定位;并能增强肿瘤细胞株的体外克隆形成能力,这种FAK突变体可能参与肿瘤的发生发展。

Objective

To investigate the subcellular localization and the biological characteristics of the novel FAK splicing mutant (FAK-Del33).

Methods

Basic experimental research applied. FAK wide-type and FAK-Del33 cDNA were cloned into pEGFP expression vector, and then transfected into breast cancer cell lines. The expression and subcellular localization of FAK wild-type and FAK-Del33 cDNA were analyzed. FAK or FAK-De133 overexpressing MDA-MB-468 were constructed. Its expression and in vitro colony forming ability was evaluated.

Results

FAK-GFP fusion protein expression plasmids were constructed and then transfected into MDA-MB-468. FAK-WT dispersed evenly in the cytoplasma while FAK-Del33 signal enriched into strong signal points at different subcellular sites; restriction enzyme analysis and sequencing confirmed the correct construction of lentivirus plasmids. The stable cell lines with expression of FAK were generated by lentivirus infection, puromycin screening and fluorescence quantitative PCR identification. Soft agar colony formation test showed that clone number from mutant FAK had significantly higher levels than FAK wide-type[(735±91)/1000 vs. (335±48)/1000, t=9.437, P<0.01).

Conclusion

This work clearly indicates that the exon 33 deletion change the subcellular localization of FAK and can enhance tumor cell line' s in vitro colonyforming ability and the FAK mutant may participate in the occurrence and development of tumor.

表1 半定量及荧光实时定量PCR的引物表
图1 免疫荧光技术检测 FAK-Del33的细胞定位图 注:FAK通过融合GFP发绿色荧光,F-actin骨架纤维由鬼笔环肽染色发红色荧光,细胞核由DAPI染色显示;细胞定位结果所示FAK-Del33呈点状不均匀分布,在胞质中聚集成簇,并在细胞浆中随机分布,偶见于细胞核,而FAK-Wt均匀弥散分布于细胞质中;细胞骨架染色显示FAK突变体较野生型肌丝减弱;Overlay重叠细胞核的着色结果可见突变体和野生型均主要表达于细胞浆内
图2 FAK重组质粒的酶切鉴定图 注: 1为 FAK-wt重组质粒;2为 FAK-Del33重组质粒;M为λDNA/HindIII标准带;箭头所示为FAK目的条带
图 3 过表达慢病毒载体PGIPZ/FAK-Del33、PGIPZ/FAK-Wt的测序鉴定图 注: 图a为 FAK-33的测序图,红色下划线所示为FAK-Del33缺失的外显子33序列;图b为 FAK-Del33突变的蛋白质序列,对应的为野生型FAK Aa 956-982缺失
图4 稳转细胞株mRNA和蛋白水平的鉴定结果图 注:图a为qPCR结果,NC为空载质粒转染组,FAK-Wt为过表达野生型FAK组,FAK-Del33为过表达FAK-Del33组,**为两组比较,差异均有统计学意义(t值分别为9.811和9.763;P均<0.01);图b为半定量PCR结果,与NC组比较,FAK-WT和FAK-Del33组明显过表达,箭头所示为外源性表达的突变体FAK cDNA;图c为蛋白水平鉴定结果,与NC组比较,FAK-WT和FAK-Del33组明显过表达
图5 检测软琼脂克隆形成实验中FAK-Del33对乳腺癌细胞株体外成瘤能力的影响 注:图a为过表达FAK-Del33的乳腺癌细胞株体外克隆形成能力增强,过表达FAK-Del33细胞株克隆数量增多,克隆体积增大;图b为过表达野生型FAK与过表达突变体FAK-Del33的乳腺癌细胞株之间的体外克隆形成能力比较,二者间差异有统计学意义(t=9.437, *P<0.01)
1
Guan JL. Role of focal adhesion kinase in integrin signalling[J]. Int J Biochem Cell Biol, 1997, 29(8-9): 1085-1096.
2
Schaller MD, Borgman CA, Cobb BS, et al. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions[J].Proc Nat Acad Sci U S A, 1992, 89(11): 5192-5196.
3
Hanks SK, Calalb MB, Harper MC, et al. Focal adhesion proteintyrosine kinase phosphorylated in response to cell attachment to fibronectin[J]. Proc Nat Acad Sci U S A, 1992, 89(18): 8487-8491.
4
Parsons JT. Focal adhesion kinase: the first ten years[J]. J Cell Sci,2003, 116(Pt 8): 1409-1416.
5
Mitra SK, Lim ST, Chi A, et al. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model[J]. Oncogene, 2006, 25(32): 4429-4440.
6
Benlimame N, He Q, Jie S, et al. FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion[J]. J Cell Biol, 2005, 171(3): 505-516.
7
Lahlou H, Sanguin-Gendreau V, Zuo D, et al. Mammary epithelialspecific disruption of the focal adhesion kinase blocks mammary tumor progression[J]. Proc Natl Acad Sci U S A, 2007,104(51): 20302-20307.
8
Fang XQ, Liu XF, Yao L, et al. Somatic mutational analysis of FAK in breast cancer: a novel gain-of-function mutation due to deletion of exon 33[J]. Biochem Biophys Res Commun, 2013. [Epub ahead of print].
9
Arold ST, Hoellerer MK, Noble ME. The structural basis of localization and signaling by the focal adhesion targeting domain[J].Structure, 2002,10(3): 319-327.
10
Liu G, Guibao CD, Zheng J. Structural insight into the mechanisms of targeting and signaling of focal adhesion kinase[J]. Mol Cell Biol,2002, 22(8): 2751-2760.
11
Hamadi A, Bouali M, Dontenwill M, et al. Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397[J]. J Cell Sci, 2005, 118(Pt 19): 4415-4425.
12
Pylayeva Y, Gillen KM, Gerald W, et al. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling[J]. J Clin Invest, 2009, 119(2): 252-266.
13
Sieg DJ, Hauck CR, Ilic D, et al. FAK integrates growth-factor and integrin signals to promote cell migration[J]. Nat Cell Biol, 2000, 2(5):249-256.
14
Basuroy S, Dunaqan M, Sheth P, et al. Hydrogen Peroxide Activates Focal Adhesion Kinase and c-Src by a PI 3-Kinase-Dependent Mechanism and Promotes Cell Migration in Caco-2 Cell Monolayers[J].AJP, 2010, 299(1): 186-195.
15
Randazzo PA, Andrade J, Miura K, et al. The Arf GTPaseactivating protein ASAP1 regulates the actin cytoskeleton[J]. Proc Nat Acad Sci U S A, 2000, 97(8): 4011-4016.
16
Hsia DA, Mitra SK, Hauck CR, et al. Differential regulation of cell motility and invasion by FAK[J]. J Cell Bio, 2003, 160(5): 753-767.
[1] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[2] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[3] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[4] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[5] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[6] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[7] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[8] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[9] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[10] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[11] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[14] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[15] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?